Synopsis: GE Vernova T&D’s ₹21,500 crore order backlog and strong earnings growth support its ₹6,000 target, though valuation concerns and margin risks may limit upside. This Large-cap stock, engaged in providing transmission equipment, grid automation solutions,...
Synopsis: Nomura has maintained an “Accumulate” rating on Dr Reddy’s Laboratories Ltd, raising its target to ₹1,740, implying ~34% upside. The view is driven by a strategic shift toward branded drugs, improving margins, pricing power, and earnings quality. Lower...
Synopsis: Citi placed Cipla Ltd on a 90-day Positive Catalyst Watch, retaining a Buy rating with a ₹1,700 target, implying 20% upside. Growth is driven by a strong US respiratory pipeline, regulatory clearances, and recovery in India business. Earnings bottoming,...
Synopsis: Prabhudas Lilladher has highlighted ICICI Bank, Shriram Finance, and others as its top high-conviction stock picks, citing strong fundamentals and growth prospects with upside potential of up to 36% from current levels. PL Capital remains constructive on...
Synopsis: ICICI Securities remains positive on Lemon Tree Hotels, citing its proposed demerger, strong expansion plans, improving occupancy levels, and growth potential from both asset-light and asset-heavy businesses. This Small-Cap Hospitality Stock, engaged in...
Synopsis: Suzlon Energy Ltd shares are in focus after UBS set a ₹72 target, implying ~22% upside. The broker is positive on Suzlon’s shift to a broader renewable platform, asset-light solar expansion, EPC-driven execution, and DevCo strategy, all expected to boost...
Synopsis: ICICI Securities issues Buy calls on Pine Labs, Aadhar Housing, Hyundai Motor India, and Coforge, citing strong growth outlooks across fintech, housing finance, autos, and IT, with 15–38% upside potential. ICICI Securities has highlighted a set of...
Synopsis: The brokerage firm assigns the pharma stock a ‘Buy’ recommendation, which suggests that there is an upside of about 26 percent, driven by solid pipeline performance, clear growth visibility, and a $214 million market potential from its new US...
Synopsis: Logistic provider shares surged 7% after Motilal Oswal reiterated a “Buy” rating with a target price of Rs. 580, implying 26% upside. The optimism is driven by strong express volume growth and a significant turnaround in the company’s PTL business margins. ...
Synopsis: Citi reiterates Buy on Pine Labs with ₹235 target, citing strong growth, operating leverage, stable workforce, improving EBITDA margins, and 18.5% revenue CAGR outlook. This share is a leading Indian fintech company providing digital payment solutions,...
